|
Volumn 90, Issue 4, 2014, Pages 353-
|
DMPA and HIV: Do we need a trial?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MEDROXYPROGESTERONE ACETATE;
CONTRACEPTIVE AGENT;
EDITORIAL;
HEALTH CARE SYSTEM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
MATERNAL MORTALITY;
MATERNAL WELFARE;
RISK ASSESSMENT;
CLINICAL TRIAL (TOPIC);
FEMALE;
HIV INFECTIONS;
RISK FACTOR;
AFRICA SOUTH OF THE SAHARA;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
HEALTH CARE POLICY;
SOUTH AFRICA;
SYSTEMATIC REVIEW (TOPIC);
ZIMBABWE;
CLINICAL TRIALS AS TOPIC;
CONTRACEPTIVE AGENTS, FEMALE;
FEMALE;
HIV INFECTIONS;
HUMANS;
MEDROXYPROGESTERONE ACETATE;
RISK FACTORS;
|
EID: 84907300032
PISSN: 00107824
EISSN: 18790518
Source Type: Journal
DOI: 10.1016/j.contraception.2014.08.008 Document Type: Editorial |
Times cited : (5)
|
References (7)
|